SPDR S&P Bank ETF Rating $69.36 +0.25 (+0.37%) As of 01:43 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest SPDR S&P Bank ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.KBE Aggregate RatingModerate Buy 2.69Holdings in KBE have an aggregate rating of Moderate Buy based on 312 analyst ratings issued in the past year covering 25 companies (26.5% of the portfolio).KBE Aggregate Price Target$69.11-0.14% DownsideHigh Prediction$69.11Average Prediction$69.11Low Prediction$69.11Holdings in KBE have an aggregate price target of $69.11 and a range of $69.11 to $69.11 covering 25 companies (26.5% of the portfolio).KBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Bank ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 KBE Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.13%CRBGCorebridge Financial$34.66-0.3%4.9351 of 5 stars2.60$37.42 8.0%15Positive News1.13%EQHEquitable$53.25-0.6%4.8791 of 5 stars2.79$61.75 16.0%14Positive News1.13%JXNJackson Financial$140.24+0.6%1.7171 of 5 stars2.57$133.80 -4.6%7Options Volume1.12%TBBKBancorp$67.07-1.0%3.5133 of 5 stars2.86$71.17 6.1%71.10%NMIHNMI$44.60-1.8%2.7568 of 5 stars2.67$48.33 8.4%6Positive News1.10%NICNicolet Bankshares$171.70+0.5%3.9828 of 5 stars2.71$183.00 6.6%7Positive NewsEx-Dividend1.07%MTGMGIC Investment$31.06-1.3%4.4876 of 5 stars2.71$30.60 -1.5%7Positive NewsInsider Trade1.07%RKTRocket Companies$13.88-2.4%3.8302 of 5 stars2.53$19.87 43.1%19Gap Down1.07%WSBCWesBanco$41.25-0.1%4.3291 of 5 stars2.71$43.20 4.7%7Positive News1.06%FBPFirst BanCorp.$28.57+0.4%3.8008 of 5 stars3.22$29.38 2.8%91.05%JPMJPMorgan Chase & Co.$359.06-0.8%4.0322 of 5 stars2.64$359.96 0.3%28Trending NewsAnalyst Upgrade1.05%BACBank of America$62.72-0.5%4.6326 of 5 stars2.78$64.08 2.2%27Trending NewsOptions Volume1.05%ESNTEssent Group$68.91-1.0%4.0222 of 5 stars2.38$71.86 4.3%81.05%PRKPark National$195.02-0.3%3.1773 of 5 stars2.00$211.00 8.2%4Positive News1.04%BNYBank of New York Mellon$165.60+0.8%4.4035 of 5 stars2.82$157.13 -5.1%17Positive News1.04%CFRCullen/Frost Bankers$163.19+0.3%3.9959 of 5 stars2.29$161.75 -0.9%14Positive News1.04%SBCFSeacoast Banking Corporation of Florida$34.57+0.6%3.2615 of 5 stars2.60$35.50 2.7%5Positive News1.03%EBCEastern Bankshares$22.26+0.8%4.4515 of 5 stars2.67$24.86 11.7%9Positive NewsInsider Trade1.03%FBKFB Financial$57.24+0.4%4.3655 of 5 stars3.14$64.67 13.0%7News CoveragePositive News1.03%PNFPPinnacle Financial Partners$101.26-0.1%4.9838 of 5 stars2.89$118.35 16.9%19Positive NewsInsider Trade1.02%SSBSouthState Bank$108.00+0.8%4.7459 of 5 stars3.00$119.64 10.8%13Positive News1.02%USBU.S. Bancorp$63.57+0.1%4.4809 of 5 stars2.72$67.06 5.5%251.02%NTRSNorthern Trust$187.94+0.3%4.1703 of 5 stars2.13$180.68 -3.9%15Positive News1.02%AXAxos Financial$97.49+0.5%4.2006 of 5 stars2.88$115.67 18.6%8Positive News1.02%UMBFUMB Financial$143.33-0.1%4.9574 of 5 stars2.87$166.54 16.2%15News CoveragePositive News This page (NYSEARCA:KBE) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersFDA Momentum is Building Around NNVC!NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies ...Smallcaps Daily | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredVDTA: One AI Infrastructure Play to Watch Before the Crowd Catches On!Vertical Data Inc (OTCQB: VDTA) is targeting the infrastructure layer beneath the AI boom, including GPU hardw...Trading Wire | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredCongress Just Opened the FloodgatesThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Bank ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Bank ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KBE Stock Alerts